Another report showed that inhibition of ERK5–MEK5 signaling induced apoptosis in leukemic cells expressing the oncogenic mutant FLT3-ITD, which is the most frequent mutation in AML. This evidence concerns the gene MAPK7 and acute myeloid leukemia.